Proatherogenic Oxidized Low-Density Lipoprotein/2-Glycoprotein I Complexes in Arterial and Venous Disease

Figure 1

Distribution of serum levels of oxLDL/β2GPI complexes measured by ELISA in 48 healthy controls and 25 patients with venous and 27 with arterial diseases (). Subjects taking statins were excluded. Mean oxLDL/β2GPI levels in arterial ( U/mL, ) and venous diseases ( U/mL, ) were significantly higher than healthy controls ( U/mL). Mean levels in arterial ( U/mL) versus venous diseases ( U/mL) were not statistically different (). OxLDL/β2GPI levels among the three groups were statistically significant (, Wilcoxon/Kruskal-Wallis Rank Sum test). Boxes represent 75/25 percentiles with the horizontal line the median for the group and whiskers the 90/10 percentile bars.